Your browser doesn't support javascript.
loading
Prevention of COVID-19: Preventive Strategies for General Population, Healthcare Setting, and Various Professions.
Moossavi, Shirin; Fehr, Kelsey; Maleki, Hassan; Seyedpour, Simin; Keshavarz-Fathi, Mahdis; Tabasi, Farhad; Heravi, Mehrdad; Sharifian, Rayka; Shafiei, Golnaz; Badihian, Negin; Kelishadi, Roya; Nematollahi, Shahrzad; Almasi, Majid; Popescu, Saskia; Keshavarz-Fathi, Mahsa; Rezaei, Nima.
Afiliação
  • Moossavi S; Department of Physiology and Pharmacology, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Fehr K; Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Maleki H; Microbiome and Microbial Ecology Interest Group (MMEIG), Universal Scientific Education and Research Network (USERN), Calgary, Canada.
  • Seyedpour S; Children's Hospital Research Institute of Manitoba, Winnipeg, MB, Canada.
  • Keshavarz-Fathi M; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada.
  • Tabasi F; Microbiome and Microbial Ecology Interest Group (MMEIG), Universal Scientific Education and Research Network (USERN), Winnipeg, MB, Canada.
  • Heravi M; Department of Medical Nanotechnology and Nano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Sharifian R; Nanomedicine Research Association (NRA), Universal Scientific Education and Research Network (USERN), Kermanshah, Iran.
  • Shafiei G; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Badihian N; Nanomedicine Research Association (NRA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Kelishadi R; School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Nematollahi S; Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran.
  • Almasi M; School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Popescu S; Department of Physiology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Keshavarz-Fathi M; Medical Education Development Network (MED_NET), Universal Scientific Education and Research Network (USERN), Zahedan, Iran.
  • Rezaei N; School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Adv Exp Med Biol ; 1318: 575-604, 2021.
Article em En | MEDLINE | ID: mdl-33973200
The disease 2019 (COVID-19) made a public health emergency in early 2020. Despite attempts for the development of therapeutic modalities, there is no effective treatment yet. Therefore, preventive measures in various settings could help reduce the burden of disease. In this chapter, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19, non-pharmaceutical approaches at individual and population level, chemoprevention, immunoprevention, preventive measures in different healthcare settings and other professions, special considerations in high-risk groups, and the role of organizations to hamper the psychosocial effects will be discussed.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / COVID-19 Limite: Humans Idioma: En Revista: Adv Exp Med Biol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / COVID-19 Limite: Humans Idioma: En Revista: Adv Exp Med Biol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá